期刊文献+

IL-1β诱导NF-κB通路对肠三叶因子治疗坏死性小肠结肠炎的影响及意义 被引量:1

Experiment on intestinal trefoil factor by IL-1β-induced NF-κB in the treatment for necrotizing enterocolitis in mice
原文传递
导出
摘要 目的研究肠三叶因子(ITF)对坏死性小肠结肠炎(NEC)新生大鼠的肠黏膜中自细胞介素1β(IL-1β)含量的影响,观察ITF对NEC新生大鼠中核因子-κB(NF-κB)的活化及胞内分布规律,探讨其在NEC发病机制中的作用。方法50只新生Wistar大鼠随机分为5组(正常对照组、正常对照给予ITF组、NEC模型组、NEC给予生理盐水组、NEC给予ITF组),每组10只,并于NEC模型后,母鼠身边喂养3d。第四天处死并取回盲部组织1~2cm固定、包埋、切片、HE染色,观察组织学变化及免疫组化表现NF-κB的表达,其他肠组织制备组织匀浆,取上清液检测IL-1β含量。结果NEC新生大鼠模型中损伤肠组织IL-1β含量明显增多,NF-κB表达增强。ITF治疗组能明显的抑制NEC新生大鼠肠组织IL-1β的产生和NF-κB(P65)的表达。结论NF-κB信号通路可能参与了NEC发病过程,并起着信号转导作用;ITF通过抑制NF-κB信号通路,减轻小肠结肠组织炎症反应,起到保护肠黏膜的作用。 Objective To study the effects of intestinal trefoil factor (ITF) on the interleukin-lβ(IL-1β) of mucosa of necrotizing enterocolitis (NEC), and the activation and intracellular distribution of NF-κB induced by ITF and its role in pathogenesis of NEC in mice. Methods Fifty Wistar mice, one day after birth were equally divided into five groups., the normal control group, normal control + ITF group, NEC model group, NEC + normal saline 0. 2ml subcutaneous injection group, and NEC + ITF group. The mice were fed as normal for three-day and killed on the 4th day The ileocecum were obtained for histological examination by HE staining and the NF-κB level , and the contents of IL- 1β were measured by immunohistochemistry and ELISA assay respectively. Results The contents of IL-1β were obvious increased in NEC models with strong NF-κ B (P65) expression. The models with ITF injection were resulted in marked decrease in IL-1βand NF-B. Conclusions The NF-κB signal route may play important roles in the predisposing factors and signal transduction of NEC. ITF may protect the mucosa by inhibition from the NF-κB signal transduction route in mice.
出处 《中华小儿外科杂志》 CSCD 北大核心 2008年第8期488-491,共4页 Chinese Journal of Pediatric Surgery
关键词 肠三叶因子 小肠结肠炎 坏死性 NF-ΚB IL-1Β Intestinal trefoil factor Enterocolitis, necrotizing NF-κB Interleukin- 1β
  • 相关文献

参考文献11

  • 1Karin M, Cao Y, Greten FR, et al. NF-kappaB in cancer: from innocent bystander to major culprit. Nature Rev Cancer, 2002, 2: 301-310.
  • 2Garg A, Aggarwal BB. Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia , 2002, 16:1053- 1068.
  • 3Dvorak B, Halpern MD, Holubec H, et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol, 2002, 282:156-164.
  • 4Hsueh W, Caplan MS , Qu XW, et al. Neonatal necrotizing enterocolitis : clinical considerations and pathogenetic concepts. Pediatr Dev Pathol, 2003,6: 6-23.
  • 5Xavier RJ, Podolsky DK. Microbiology, How to get alongfriendly microbes in a hostile world. Science, 2000, 289: 1483- 1484.
  • 6Karin M, Delhase M. The I kappa B (IKK) and NF-kappa B: key elements of proinflammatory signaling. Semin Immunol, 2000, 12:85-98.
  • 7Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro-and counter-inflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics, 1999,103 : 766-771.
  • 8Wu GD, Lai EJ, Huang N. Oct I and CCAAT/enhancerbinding protein (C/EBP) bind to overlapping elements within the interleukin-8 promoter: the role of Oct-1 as a transcriptional repressor. J Biol Chem, 1997,272: 2396-2403.
  • 9Karin M, Cao Y, Greten FR, et al. NF kappaB in cancer: from innocent bystander to major culprit. Nature Rev Cancer, 2002, 2: 301-310.
  • 10Bacuerle PA, Baltimore D. Ⅰ kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science, 1998, 242: 540-546.

同被引文献15

  • 1Neu J, Walker WA. Necrotizing enterocolitis[J]. N Engl J Med, 2011, 364(3): 255-264.
  • 2Zhao L, Lu W. Defensins in innate immunity[J]. Curr Opin Hematol, 2014, 21(1): 37-42.
  • 3Sheng Q, Lv Z, Cai W, et al. Protective effects of hydrogen- rich saline on necrotizing enterocolitis in neonatal rats[J]. J Pediatr Surg, 2013, 48(8): 1697-1706.
  • 4Wynn J, Cornell "IT, Wong HR, et al. The host response to sepsis and developmental impact [J]. Pediatrics, 2010, 125 (5) : 1031-1041.
  • 5WeitkampJH, Koyama T, Rock MT, et al. Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory ( FOXP3 )/effector ( CIM, CDS) T cell ratios[J]. Gut, 2013, 62(1): 73-82.
  • 6Armogida SA, Yannaras NM, Melton AL, et al. Identification and quantification of innate immune system mediators in human breast milk[J]. Allergy Asthma Proc, 2004, 25(5): 297-304.
  • 7JenkeAC, Zilbauer M, Postberg J, et al. Human beta- defensin 2 expression in ELBW infants with severe necrotizing enterocolitis[J]. Pediatr Res, 2012, 72(5) : 513-520.
  • 8Schmidtchen A. The multiple faces of host defence peptides and proteins[J]. J Innate Immun, 2012, 4(4): 325-326.
  • 9Bhatia AM,Stoll BJ, Cismowski MJ, et al. Cytokine levels in the preterm infant with neonatal intestinal injury[J]. Am J Perinatol, 2013, 31 (6) : 489-496.
  • 10De Plaen IG. Inflammatory signaling in necrotizing enterocolitis[J]. Clin Perinatol, 2013, 40(1) : 109-124.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部